CPC A61K 9/0019 (2013.01) [A61K 9/08 (2013.01); A61K 38/47 (2013.01); A61K 39/001106 (2018.08); A61K 39/39591 (2013.01); A61K 47/183 (2013.01); A61K 47/20 (2013.01); A61K 47/26 (2013.01); A61P 35/00 (2018.01); C07K 16/32 (2013.01); C12Y 302/01035 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/585 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); C07K 2317/24 (2013.01); C07K 2317/56 (2013.01); C07K 2317/90 (2013.01)] | 30 Claims |
1. An article of manufacture containing a single fixed dose of a HER2 antibody comprising the variable light chain and variable heavy chain amino acid sequences of SEQ ID Nos. 7 and 8, respectively, wherein the fixed dose is 600 mg or 1200 mg.
|